companydata.dkPHARMA EVIDENCE ApS: Financial statements 2012
CVR: 34586519
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 868,148 and a net result of DKK -447,585. Equity amounted to DKK 409,973. The solvency ratio was 62.1%.
- Gross Profit
- 868,148 kr.
- Profit/Loss
- -447,585 kr.
- Equity
- 409,973 kr.
- Total Assets
- 660,129 kr.
How creditworthy is PHARMA EVIDENCE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of May 29, 2012, Tove Holm-Larsen is registered as director of PHARMA EVIDENCE ApS.
PHARMA EVIDENCE ApS was founded on May 29, 2012.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 2 employees. In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity amounted to DKK 134,401.